Nicholas Jason Singer 13D and 13G filings for BROOKLYN IMMUNO THERAPEUTICS L:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-20 4:30 pm Sale |
2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 26,251 7.670% |
-113,416 (-81.20%) |
Filing |
| 2022-02-16 5:15 pm Sale |
2021-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 6,983 4.000% |
-5,657 (-44.75%) |
Filing |
| 2021-04-30 4:05 pm Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 12,640 9.130% |
12,640 (New Position) |
Filing |